BioCryst Pharmaceuticals Inc. logo

BioCryst Pharmaceuticals Inc. (BCRX)

Market Closed
15 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
8. 02
-0.03
-0.3727%
Pre Market
$
8. 47
+0.45 +5.611%
2.17B Market Cap
- P/E Ratio
- Div Yield
4.5M Volume
-0.62 Eps
$ 8.05
Previous Close
Add Transaction
Day Range
7.95 8.24
Year Range
6.23 11.22
Want to track BCRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

BioCryst Pharmaceuticals Inc. (BCRX) Statistics

Valuation metrics

Market Cap 2.17B
Enterprise value 2.43B
Trailing P/E (ttm) -5.94
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 2.31
Price/Book (mrq) -4.79
Enterprise Value/Revenue 2.58
Enterprise Value/EBITDA -8.01

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4.59M
Average volume (90 days) 3.46M

Price summary

52-Week low 6.23
52-Week high 11.22
Beta -
50-Day moving average 8.85
200-Day moving average 9.2

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -0.41%
Operating margin -0.33%

Operational effectiveness

Return on assets -0.69%
Return on equity 1.02%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 3.7
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.51
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 1.39
Total debt (mrq) -
Total Debt/Equity (mrq) -0.9
Current ratio (mrq) 2.32%
Book value per share (mrq) -1.79

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -